Under NBI (Narrow Band Imaging) and magnifying endoscopy, study on the usefulness of rebamipide as a pretreatment for improvement of endoscopic view in the gastric mucosa.

Under NBI (Narrow Band Imaging) and magnifying endoscopy, study on the usefulness of rebamipide as a pretreatment for improvement of endoscopic view in the gastric mucosa. - The usefulness of rebamipide as a pretreatment for improvement of endoscopic view.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006980

Enrollment

100

Registered

2011-12-28

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

Take 1 tablet of rebamipide three times a day , 9 days before endoscopy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for taking endoscopy from whom informed cosent was obtained.

Exclusion criteria

Exclusion criteria: Post operative stomach

Design outcomes

Primary

Measure	Time frame
We score mucosal microvascular structure and mucosal microsurface structure under white light imaging and higher magnification endoscopic view at anterior wall of antrum, lesser curvature of lower gastric body,greater curvature of upper gastric body,and then we evaluate the total points of score.	—

Countries

Japan

Contacts

Public Contactnishiyama noriko

Kagawa university Department of gastroenterology and neurology

0878912156

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026